- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment in Subjects with Schizophrenia
This study is looking at a new medicine called Valbenazine for people with schizophrenia. It aims to see if adding Valbenazine to existing treatments helps reduce symptoms and improve daily life over 10 weeks. Some people will get the medicine, others a dummy pill.
For: SchizophreniaBulgaria · Croatia · Czechia - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment in Subjects with Schizophrenia
This study is testing a new medicine, Valbenazine, for people with schizophrenia. Researchers want to see if it helps improve symptoms when taken alongside other treatments, how safe it is, and if people can tolerate it well.
For: SchizophreniaRomania · Czechia · Spain - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy
This study is looking into a new medicine called Valbenazine for adults with movement problems caused by cerebral palsy. It aims to see if the medicine helps reduce uncontrolled movements and if it's safe to use. Patients will be compared to others receiving a dummy medicine.
For: Dyskinesia due to cerebral palsy (DCP)Portugal · Belgium · Spain